Table 1.
Clinicopathological characteristics of patients with clear cell carcinoma of the uterine cervix (N = 50).
| Variables | N | (%) |
|---|---|---|
| Age | ||
| <40 years | 25 | 50 |
| ≥40 years | 25 | 50 |
| FIGO 2009 stage | ||
| IA | 2 | 4 |
| IB | 34 | 68 |
| IIA | 12 | 24 |
| IIB | 2 | 4 |
| Tumour size | ||
| <4 cm | 33 | 66 |
| ≥4 cm | 17 | 34 |
| Parametrial involvement | ||
| Yes | 4 | 8 |
| No | 46 | 92 |
| LVSI | ||
| Yes | 6 | 12 |
| No | 44 | 88 |
| Depth of stromal invasion | ||
| <1/2 | 29 | 58 |
| ≥1/2 | 21 | 42 |
| Lymph node metastasis | ||
| No | 45 | 90 |
| Yes | 5 | 10 |
| Neoadjuvant therapy | ||
| Yes | 10 | 20 |
| No | 40 | 80 |
| Adjuvant therapy | ||
| Chemotherapy | 18 | 36 |
| Radiotherapy | 6 | 12 |
| Chemoradiotherapy | 22 | 44 |
| None | 4 | 8 |
FIGO: International Federation of Gynaecology and Obstetrics; LVSI: lymphovascular space invasion.